Daniel Lerman, MD, is an orthopaedic oncologist and sarcoma surgeon at the University of Maryland Greenebaum Cancer Center. His clinical expertise includes limb-sparing surgery and biological reconstructive procedures for sarcoma, the treatment of advanced benign musculoskeletal conditions such as bone and soft tissue tumors, avascular necrosis,osteoarthritis, and complex/revision total joint reconstructions.

After graduating from the University of Maryland School of Medicine, Dr. Lerman completed his residency in orthopaedic surgery at the prestigious NYU Hospital for Joint Diseases. His training continued at the Huntsman Cancer Institute at the University of Utah, where he completed fellowships in both basic science oncology research and sarcoma surgery. His research interests include the investigation of novel targeted therapeutics for sarcoma and optimization of functional outcomes following surgical intervention.

Dr. Lerman is the author of several peer-reviewed scientific articles, review articles, and book chapters on the topics of sarcoma therapy and metastatic bone disease. In addition, he has presented his research at national and international conferences. He is currently a member of the American Academy of Orthopaedic Surgeons, the Musculoskeletal Tumor Society, and the Connective Tissue Oncology Society.

investigation of novel targeted therapeutics for sarcoma and optimization of functional outcomes following surgical intervention